The global, regional, and national burden of acute pancreatitis in 204 countries and territories, 1990–2019

Abstract Background Acute pancreatitis is a common and potentially lethal gastrointestinal disease, but literatures for the disease burden are scarce for many countries. Understanding the current burden of acute pancreatitis and the different trends across various countries is essential for formulating effective preventive intervenes. We aimed to report the incidence, mortality, and disability-adjusted life-years (DALYs) caused by acute pancreatitis in 204 countries and territories between 1990 and 2019. Methods Estimates from the Global Burden of Disease Study 2019 (GBD 2019) were used to analyze the epidemiology of acute pancreatitis at the global, regional, and national levels. We also reported the correlation between development status and acute pancreatitis’ age-standardized DALY rates, and calculated DALYs attributable to alcohol etiology that had evidence of causation with acute pancreatitis. All of the estimates were shown as counts and age-standardized rates per 100,000 person-years. Results There were 2,814,972.3 (95% UI 2,414,361.3–3,293,591.8) incident cases of acute pancreatitis occurred in 2019 globally; 1,273,955.2 (1,098,304.6–1,478,594.1) in women and 1,541,017.1 (1,307,264.4–1,814,454.3) in men. The global age-standardized incidence rate declined from 37.9/100,000 to 34.8/100,000 during 1990–2019, an annual decrease of 8.4% (5.9–10.4%). In 2019, there were 115,053.2 (104,304.4–128,173.4) deaths and 3,641,105.7 (3,282,952.5–4,026,948.1) DALYs due to acute pancreatitis. The global age-standardized mortality rate decreased by 17.2% (6.6–27.1%) annually from 1.7/100,000 in 1990 to 1.4/100,000 in 2019; over the same period, the age-standardized DALY rate declined by 17.6% (7.8–27.0%) annually. There were substantial differences in the incidence, mortality and DALYs across regions. Alcohol etiology attributed to a sizable fraction of acute pancreatitis-related deaths, especially in the high and high-middle SDI regions. Conclusion Substantial variation existed in the burden of acute pancreatitis worldwide, and the overall burden remains high with aging population. Geographically targeted considerations are needed to tailor future intervenes to relieve the burden of acute pancreatitis in specific countries, especially for Eastern Europe.

Download Full-text

Systematic Analysis of the Global, Regional and National Burden of Cardiovascular Diseases from 1990 to 2017

Journal of Epidemiology and Global Health ◽

10.1007/s44197-021-00024-2 ◽

2021 ◽

Author(s):

Zhenkun Wang ◽

Aihua Du ◽

Hong Liu ◽

Ziwei Wang ◽

Jifa Hu

Keyword(s):

Risk Factors ◽

Cardiovascular Diseases ◽

Mortality Rate ◽

Systematic Analysis ◽

Disability Adjusted Life ◽

Life Years ◽

National Burden ◽

Comparative Risk ◽

Disease Study ◽

Standardized Mortality Rate

Abstract Background Previous studies on the burden of cardiovascular diseases (CVDs) were mainly based on limited data of the study period or area, or did not include detailed risk factor analysis. Objective To investigate up-to-date temporal and regional trends and risk factors of mortality and disability-adjusted life years (DALYs) attributed to CVDs by age, sex, and disease throughout the world. Methods Data for the disease burden of CVDs in 195 countries and territories from 1990 to 2017, including mortality, DALYs, age-standardized mortality rates, and age-standardized DALY rates, were estimated from the Global Burden of Disease Study 2017. Risk factors attributable to deaths and DALYs for CVDs were also estimated using the comparative risk assessment framework. Results The number of deaths from CVDs increased by 48.62%, from 11.94 (95% UI 11.78–12.18) million in 1990 to 17.79 (17.53–18.04) million in 2017. However, the age-standardized mortality rate decreased by an average of − 1.45% (− 1.72% to − 1.18%) annually. After fluctuation in the expected age-standardized mortality rate of CVDs in most of the socio-demographic index (SDI) scale, these rates decrease rapidly for SDI values of 0.7 and higher. In 2017, metabolic risks accounted for 73.48% of deaths and 73.25% of DALYs due to CVDs, behavioral factors accounted for 63.23% of deaths and 66.71% of attributable DALYs. Conclusion CVDs remain a major global health burden due to the increment in death numbers and DALYs. Aging and the main risk factors are the main drivers of mortality and health loss. More attention to main risk factors should be paid with supportive health policies.

Download Full-text

Global, regional, and national burden of other musculoskeletal disorders 1990–2017: results from the Global Burden of Disease Study 2017

Rheumatology ◽

10.1093/rheumatology/keaa315 ◽

2020 ◽

Author(s):

Saeid Safiri ◽

Ali Asghar Kolahi ◽

Marita Cross ◽

Kristin Carson-Chahhoud ◽

Amir Almasi-Hashiani ◽

...

Keyword(s):

Burden Of Disease ◽

National Level ◽

Point Prevalence ◽

Global Burden Of Disease ◽

Global Burden ◽

Disability Adjusted Life ◽

Life Years ◽

Prevalence Estimates ◽

National Burden ◽

Disease Study

Abstract Objectives To describe the level and trends of point prevalence, deaths and disability-adjusted life years (DALYs) for other musculoskeletal (MSK) disorders, i.e. those not covered by specific estimates generated for RA, OA, low back pain, neck pain and gout, from 1990 to 2017 by age, sex and sociodemographic index. Methods Publicly available modelled estimates from the Global Burden of Disease (GBD) 2017 study were extracted and reported as counts and age-standardized rates per 100 000 population for 195 countries and territories between 1990 and 2017. Results Globally, the age-standardized point prevalence estimates and deaths rates of other MSK disorders in 2017 were 4151.1 and 1.0 per 100 000. This was an increase of 3.4% and 7.2%, respectively. The age-standardized DALY rate in 2017 was 380.2, an increase of 3.4%. The point prevalence estimate was higher among females and increased with age. This peaked in the 65–69 year age group for both females and males in 2017, followed by a decreasing trend for both sexes. At the national level, the highest age-standardized point prevalence estimates in 2017 were seen in Bangladesh, India and Nepal. The largest increases in age-standardized point prevalence estimates were observed in Romania, Croatia and Armenia. Conclusion The burden of other MSK disorders is proven to be substantial and increasing worldwide, with a notable intercountry variation. Data pertaining to specific diseases within this overarching category are required for future GBD MSK estimates. This would enable policymakers to better allocate resources and provide interventions appropriately.

Download Full-text

Epidemiological Trends of Urinary Tract Infections at the Global, Regional, and National Levels from 1990-2017: A Population-Based Study

10.21203/rs.3.rs-142162/v1 ◽

2021 ◽

Author(s):

Cong Zhu ◽

Qiao Huang ◽

Li-Sha Luo ◽

Tong Deng ◽

Jia-Min Gu ◽

...

Keyword(s):

Urinary Tract ◽

United Arab Emirates ◽

Urinary Tract Infections ◽

Population Based ◽

Disability Adjusted Life ◽

Life Years ◽

Incidence And Mortality ◽

Disease Study ◽

Tract Infections ◽

Incident Cases

Abstract BackgroundUrinary tract infections (UTIs) are some of the most common infections worldwide and consume a lot of medical resources every year. However, there were a lack of available data on its incidence and disease burden. We armed to investigate incidence, mortality, and disability adjusted life-years (DALYs) of urinary tract infections (UTIs) from 1990 to 2017.MethodsWe extracted data from the Global Burden of Disease Study 2017, then calculated estimated annual percentage changes (EAPC) of age-standardized incidence rate (ASIR), age-standardized death rate (ASDR), and age-standardized DALYs rate at global, national, regional, and socio-demographic index (SDI) level.ResultsFrom 1990 to 2017, the globally incident cases (+52.09%), death cases (+140.10%), and DALYs (+69.65%) of UTIs all increased. The ASIR, ASDR, and age-standardized DALYs rate showed upward trends with the EAPC of +0.10 (95%CI: 0.07 to 0.12), +0.72 (95%CI: 0.65-0.78), and +0.06 (95%CI: -0.05 to 0.16), respectively. The ASIR decreased only in the high-middle SDI quantile (-0.26, 95%CI: -0.3 to -0.23). United Arab Emirates had the largest increase of DALYs (+835.04%), but Bulgaria had the largest decrease (-80.74%). EAPC for incidence and mortality were below 0 mainly in Europe and East Asia. In 2017, the incident cases (+3.44 times), the deaths (+1.31 times), and DALYs (+1.21 times) were all higher in females than males. The incident cases were mainly concentrated in 15-49 years old; DALYs and mortality were higher in over 80 age groups.ConclusionsGlobally, the burden of UTIs increased from 1990 to 2017, especially in females; however, distinct varies were observed in different regions and countries. The infants and elders are easier to die when they suffer from UTIs.

Download Full-text

Burden of multiple sclerosis in Iran from 1990 to 2017

BMC Neurology ◽

10.1186/s12883-021-02431-1 ◽

2021 ◽

Vol 21 (1) ◽

Author(s):

Nima Fattahi ◽

Sahar Saeedi Moghaddam ◽

Farnam Mohebi ◽

Negar Rezaei ◽

Masoud Masinaei ◽

...

Keyword(s):

Multiple Sclerosis ◽

Incidence Rate ◽

National Level ◽

Uncertainty Interval ◽

Policy Makers ◽

Disability Adjusted Life ◽

Life Years ◽

The Central Nervous System ◽

Disease Study ◽

Standardized Mortality Rate

Abstract Background Multiple Sclerosis (MS) is a burdensome, chronic and autoimmune disease of the central nervous system. We aimed to report the incidence, prevalence, mortality, and Disability Adjusted Life Years (DALYs) of MS in Iran at a national level for different age and sex groups over a period of 28 years (1990–2017). Methods Data were extracted from the Global Burden of Disease study (GBD) from 1990 to 2017, published by the Institute for Health Metrics and Evaluation. The incidence of DALYs and prevalence of MS were estimated to report the burden of MS based on sex and age in Iran from 1990 to 2017. Results At the national level, the Age-Standardized Incidence Rate (ASIR), Age-Standardized Prevalence Rate (ASPR), Age-Standardized DALYs Rate (ASDR) and the Age-Standardized Mortality Rate (ASMR) in Iran in 2017 were 2.4 (95% Uncertainty Interval [UI]: 2.1 to 2.7), 69.5 (62.1 to 77.8), 29.1 (23.6 to 34.7), and 0.4 (0.3 to 0.4) per 100,000 population, respectively. During the period of 1990 to 2017, all measures increased, and were higher among females. The incidence rate began upward trend at the age of 20 and attained its highest level at the age of 25. Conclusion In Iran, all of the age-standardized MS rates have been increasing during the 28 years from 1990 to 2017. Our findings can help policy makers and health planners to design and communicate their plans and to have a better resource allocation, depending on the incidence and prevalence of the growing numbers of MS patients in Iran.

Download Full-text

Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019

BMC Cancer ◽

10.1186/s12885-021-08280-y ◽

2021 ◽

Vol 21 (1) ◽

Author(s):

Linghui Zhou ◽

Qin Yu ◽

Guoqing Wei ◽

Linqin Wang ◽

Yue Huang ◽

...

Keyword(s):

Multiple Myeloma ◽

United Arab Emirates ◽

Western Europe ◽

Population Aging ◽

Health Concern ◽

Global Burden ◽

Life Years ◽

National Burden ◽

Disease Study ◽

Incident Cases

Abstract Background Multiple myeloma (MM) is a major health concern. Understanding the different burden and tendency of MM in different regions is crucial for formulating specific local strategies. Therefore, we evaluated the epidemiologic patterns and explored the risk factors for MM death. Methods Data on MM were collected from the 2019 Global Burden of Disease study. We used incidence, mortality, and disability adjusted life-years to estimate the global, regional, and national burden of MM. Results In 2019, there were 155,688 (95% UI, 136,585 – 172,577) MM cases worldwide, of which 84,516 (54.3%, 70,924 – 94,910) were of men. The age-standardized incidence rate (ASIR) was 1.72/100,000 persons (95% UI, 1.59–1.93) in 1990 and 1.92/100,000 persons (95% UI, 1.68–2.12) in 2019. The number of MM deaths increased 1.19-fold from 51,862 (95% UI, 47,710–58,979) in 1990 to 113,474 (95% UI, 99,527 – 121,735) in 2019; the age-standardized death rate (ASDR) was 1.42/100,000 persons (95% UI, 1.24–1.52) in 2019. In recent 15 years, ASDR showed a steady tendency for men, and a downward tendency for women. Countries with high social-demographic indexes exhibited a higher ASIR and ASDR. Australasia, North America, and Western Europe had the highest ASIR and ASDR, with 46.3% incident cases and 41.8% death cases. Monaco had the highest ASIR and ASDR, which was almost half as high as the second highest country Barbados. In addition, United Arab Emirates and Qatar had the largest growth multiple in ASIR and ASDR, which was twice the third country Djibouti. Conclusions Globally, incident and death MM cases have more than doubled over the past 30 years. The increasing global burden may continue with population aging, whereas mortality may continue to decrease with the progression of medical technology. The global burden pattern of MM was diverse, therefore specific local strategies based on different burden patterns for MM are necessary.

Download Full-text

Global burden for dengue and the evolving pattern in the past 30 years

Journal of Travel Medicine ◽

10.1093/jtm/taab146 ◽

2021 ◽

Author(s):

Xiaorong Yang ◽

Mikkel B M Quam ◽

Tongchao Zhang ◽

Shaowei Sang

Keyword(s):

Southeast Asia ◽

South Asia ◽

Human Mobility ◽

Viral Disease ◽

Global Burden ◽

Disability Adjusted Life ◽

Life Years ◽

National Burden ◽

Global Burden Of Diseases ◽

Incident Cases

Abstract Background: Dengue is the most prevalent and rapidly spreading mosquito-borne viral disease. We present the global, regional, and national burden of dengue from 1990 to 2019 based on the findings from the Global Burden of Diseases, Injures, and Risk Factors Study 2019 (GBD 2019). Methods: Based upon GBD 2019 dengue data on age-standardized incidence rate (ASIR), age-standardized death rate (ASDR) and age-standardized disability-adjusted life years (DALYs) rate, this study estimates and presents annual percentage change (EAPC) to quantify trends over time to assess potential correlates of increased dengue activity such as global travel, and warming. Results: Globally from 1990 to 2019, dengue incident cases, deaths and DALYs gradually increased. Those under 5, once accounting for the largest portion of deaths and DALYs in 1990, were eclipsed by those 15–49 years old in 2019. Age standardized incidence (ASIR: EAPC 3.16, 95%CI: 2.90–3.43), death (ASDR: EAPC 5.42, 95%CI: 2.64–8.28), and DALY rates (EAPC 2.31, 95%CI: 2.00–2.62) accelerated most among high-middle and high socio-demographic index (SDI) regions. Southeast Asia and South Asia had most of the dengue incident cases, deaths and DALYs, but East Asia had the fastest rise in ASIR (EAPC 4.57, 95%CI: 4.31, 4.82), while Tropical Latin America led in ASDR (EAPC 11.32, 95%CI: 9.11, 13.58) and age-standardized DALYs rate (EAPC 4.13, 95%CI: 2.98, 5.29). SDI showed consistent bell shape relationship with ASIR, ASDR and age-standardized DALYs rate. Global Land-Ocean Temperature Index and air passenger travel metrics were found to be remarkably positively correlated with dengue burden. Conclusions: The burden of dengue has become heavier from 1990 to 2019, amidst the three decades of urbanization, warming climates and increased human mobility in much of the world. Southeast Asia and South Asia remain regions of concern, especially in conjunction with the Americas swift rise in dengue burden.

Download Full-text

Global Burden of Sexually Transmitted Infections: 1990 - 2019

10.21203/rs.3.rs-847312/v1 ◽

2021 ◽

Author(s):

Jiaofeng Huang ◽

Su Lin ◽

Jinshui Pan ◽

Lingling Lu ◽

Bang Liu ◽

...

Keyword(s):

Sexually Transmitted Infections ◽

Incidence Rate ◽

Disease Burden ◽

Global Burden ◽

Sexually Transmitted ◽

Disability Adjusted Life ◽

Younger Age ◽

Life Years ◽

Disease Study ◽

Incident Cases

Abstract BackgroundSexually transmitted infections (STIs) are major public health problems worldwide. Understanding the disease burden are crucial for health policy making. This study was to assess global and regional STIs incidence, mortality and disability‐adjusted life years (DALYs) from 1990 to 2019.MethodsData were extracted from the Global Burden of Disease study 2019, which is an open database for download. Age-standardized rate and estimated annual percentage changes (EAPC) were calculated to evaluate the burden of STIs over time.ResultsIn 2019, the total number of incident cases of STIs was 769.85 million worldwide. The age-standardized incidence rate was stable from 1990 to 2019 with the EAPC of −0.04 (95% UI: −0.09 to 0.01). In 2019, the number of deaths caused by STIs was 89.89×103, which was 15.51% lower than that of 1990 (106.52×103). A decreasing trend from 1990 to 2019 was observed in the age-standardized death and DALYs. The age-standardized death and DALYs rate due to STIs were the highest in the younger age (<14 years old). As for different diseases, syphilis was the least common STIs with an age-standardized incidence rate of 178.48/100,000, while syphilis was also the main contributor to the age-standardized death and DALYs rate. These two indicators were negatively associated with sociodemographic level.ConclusionsThe global incidence of STIs has been persistently high from 1990 to 2019, while the age-standardized death and DALYs rate has decreased recently. More attention should be paid to the younger population, patients with syphilis and regions with low sociodemographic index.

Download Full-text

Global, Regional, and National Burden of Multiple Myeloma from 1990 to 2019: Estimates from the 2019 Global Burden of Disease study

10.21203/rs.3.rs-129181/v1 ◽

2020 ◽

Author(s):

Linghui Zhou ◽

Qin Yu ◽

Guoqing Wei ◽

Linqin Wang ◽

Yue Huang ◽

...

Keyword(s):

United Arab Emirates ◽

Burden Of Disease ◽

Population Aging ◽

Global Burden Of Disease ◽

Health Concern ◽

Global Burden ◽

Life Years ◽

National Burden ◽

Disease Study ◽

Incident Cases

Abstract BackgroundMultiple myeloma (MM) is a major health concern. Understanding the different burden and tendency of MM in different regions is crucial for formulating specific local strategies. Therefore, we evaluated the epidemiologic patterns and explored the risk factors for MM death.MethodsData on MM were collected from the 2019 Global Burden of Disease study. We used incidence, mortality, and disability adjusted life-years to estimate the global, regional, and national burden of MM. ResultsIn 2019, there were 155,688 (95% UI, 136,585 – 172,577) MM cases worldwide, of which 84,516 (54.3%, 70,924 – 94,910) were of men. The age-standardized incidence rate (ASIR) was 1.72/100,000 persons (95% UI, 1.59 – 1.93) in 1990 and 1.92/100,000 persons (95% UI, 1.68 - 2.12) in 2019. The number of MM deaths increased 1.19-fold from 51,862 (95% UI, 47,710–58,979) in 1990 to 113,474 (95% UI, 99,527 – 121,735) in 2019; the age-standardized death rate (ASDR) was 1.42/100,000 persons (95% UI, 1.24 - 1.52) in 2019. Countries with high social-demographic indexes exhibited a higher ASIR and ASDR. Australasia, North America, and Western Europe had the highest ASIR and ASDR, with 46.3% incident cases and 41.8% death cases. Monaco had the highest ASIR and ASDR, which was almost half as high as the second highest country Barbados. In addition, United Arab Emirates and Qatar had the largest growth multiple in ASIR and ASDR, which was twice the third country Djibouti.ConclusionsGlobally, incident and death MM cases have more than doubled over the past 30 years. The increasing global burden may continue with population aging, whereas mortality may continue to decrease with the progression of medical technology. The global burden pattern of MM was diverse, therefore specific local strategies based on different burden patterns for MM are necessary.

Download Full-text

Global, Regional, and National Burden of Urinary Tract Infections from 1990-2019: an Analysis of the Global Burden of Disease Study 2019

10.21203/rs.3.rs-829349/v1 ◽

2021 ◽

Author(s):

Zhilin Zeng ◽

Juan Zhan ◽

Kaimin Zhang ◽

Huilong Chen ◽

Sheng Cheng

Keyword(s):

Incidence Rate ◽

National Level ◽

Disability Adjusted Life Years ◽

Development Status ◽

Disability Adjusted Life ◽

Life Years ◽

Study Results ◽

National Burden ◽

Disease Study ◽

Tract Infections

Abstract Objective We aimed to estimate the burden of UTIs by age, sex, and socioeconomic status in 204 countries and territories from 1990–2019. Method We used data from GBD 2019 to analyse the incidence, mortality, and disability-adjusted life-years (DALYs) due to UTIs at the global, regional, and national levels. Estimates are presented as numbers and age-standardised or age-specific rates per 100000 population, with 95% uncertainty intervals (UIs). We further explored the associations between the incidence, mortality, DALYs, and socio-demographic index (SDI) as a proxy for the development status of regions and countries. Results In 2019, more than 404.6 million (95% UI 359.4-446.5) individuals had UTIs globally and nearly 236 786 people (198 433 − 259 034) died of UTIs, contributing to 5.2 million (4.5–5.7) DALYs. The age-standardised incidence rate increased from 4 715.0 (4 174.2-5 220.6) per 100 000 population in 1990 to 5 229.3 (4 645.3-5 771.2) per 100 000 population in 2019. At the GBD regional level, the highest age-standardised incidence rate in 2019 occurred in Tropical Latin America (13 852.9 [12 135.6–15 480.3] per 100 000 population). At the national level, Ecuador had the highest age-standardised incidence rate (15 511.3 [13 685.0–17 375.6] per 100 000 population). The age-standardised death rates were highest in Barbados (19.5 [13.7–23.5] per 100 000 population). In addition, age-standardised incidence, death, and DALY rates generally increased across the SDI. Conclusions Our study results suggest a globally rising trend of UTI burden between 1990 and 2019. The results of this study could be useful in policy-making, priority setting, and resource allocation in UTI prevention and treatment.

Download Full-text